Anjana Pillai, MD

Articles

Advanced Biliary Tract Cancers: Novel Biomarker Strategies

November 9th 2022

Closing out their discussion on the management of biliary tract cancers, experts share excitement for future evolutions in the treatment landscape.

Novel Agents Being Explored in Advanced Biliary Tract Cancers

November 9th 2022

Expert panelists provide comprehensive insight on novel targeted agents being investigated in advanced biliary tract cancers.

Sequencing Therapy in Patients With Advanced Biliary Tract Cancers

November 2nd 2022

In the context of advanced biliary tract cancers, panelists reflect on the optimal sequencing of agents throughout multiple lines of therapy.

Advanced BTC: Informing Use of IO Therapy in Specific Patient Populations

October 26th 2022

Shared insight on efforts to identify patient subgroups that may benefit more from immunotherapy in the setting of advanced biliary tract cancers.

Advanced Biliary Tract Cancers: First- and Second-Line Chemotherapy

October 19th 2022

Focused discussion on chemotherapy treatment options commonplace in patients with advanced or metastatic biliary tract cancers.

An Overview of Systemic Therapy for Advanced Biliary Tract Cancers

October 19th 2022

Shifting their focus to the advanced disease setting, panelists provide a comprehensive overview on systemic treatment modalities used in biliary tract cancers.

Understanding the Role of Adjuvant Therapy in Biliary Tract Cancers

October 12th 2022

Experts provide brief perspective on the use of adjuvant treatment approaches for patients with biliary tract cancers.

What is the Role of Transplant in Early-Stage Biliary Tract Cancers?

October 12th 2022

Before closing out their review of early-stage biliary tract cancer treatment options, panelists consider the role of transplant in the setting.

Dr. Pillai on Sequential Treatment in HCC

March 16th 2021

Anjana Pillai, MD, discusses sequential treatment in hepatocellular carcinoma.

Dr. Pillai on the Importance of Multidisciplinary Discussion in HCC

March 10th 2021

Anjana Pillai, MD, discusses the importance of multidisciplinary discussion in hepatocellular carcinoma.